Refine
Year of publication
Document Type
- Journal article (7624)
- Doctoral Thesis (2803)
- Book article / Book chapter (133)
- Conference Proceeding (108)
- Preprint (107)
- Working Paper (66)
- Review (43)
- Report (27)
- Master Thesis (26)
- Book (20)
Language
- English (10983) (remove)
Keywords
- Toxikologie (119)
- Medizin (99)
- inflammation (91)
- Psychologie (86)
- Biochemie (85)
- cancer (80)
- Organische Chemie (68)
- gene expression (68)
- Anorganische Chemie (66)
- Maus (64)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (1905)
- Graduate School of Life Sciences (799)
- Physikalisches Institut (595)
- Institut für Psychologie (492)
- Neurologische Klinik und Poliklinik (388)
- Medizinische Klinik und Poliklinik II (372)
- Institut für Organische Chemie (366)
- Medizinische Klinik und Poliklinik I (357)
- Institut für Anorganische Chemie (353)
- Institut für Molekulare Infektionsbiologie (353)
Schriftenreihe
- Cultural Animal Studies, Band 3 (24)
- Berichte aus der Informatik (1)
- Deuterocanonical and Cognate Literature Studies (1)
- Deuterocanonical and Cognate Literature Yearbook (1)
- International Archives of the History of Ideas / Archives internationales d’histoire des idées 242 (1)
- Methods in Molecular Biology 2533 (1)
- Methods in Molecular Biology; 2643 (1)
Sonstige beteiligte Institutionen
- VolkswagenStiftung (24)
- Johns Hopkins School of Medicine (17)
- Helmholtz Institute for RNA-based Infection Research (HIRI) (7)
- IZKF Nachwuchsgruppe Geweberegeneration für muskuloskelettale Erkrankungen (7)
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (5)
- Fraunhofer-Institut für Silicatforschung ISC (5)
- Johns Hopkins University School of Medicine (5)
- Wilhelm-Conrad-Röntgen-Forschungszentrum für komplexe Materialsysteme (5)
- Bernhard-Heine-Centrum für Bewegungsforschung (4)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (4)
- Zentraleinheit Klinische Massenspektrometrie (4)
- Cologne Game Lab (3)
- Technische Hochschule Nürnberg Georg Simon Ohm (3)
- Center for Interdisciplinary Clinical Research, Würzburg University, Würzburg, Germany (2)
- DFG Forschungsgruppe 2757 / Lokale Selbstregelungen im Kontext schwacher Staatlichkeit in Antike und Moderne (LoSAM) (2)
- Department of Biomedical Imaging, National Cerebral and Cardiovascular Research Center, Suita, Japan (2)
- Deutsches Zentrum für Luft- und Raumfahrt (DLR), Institut für Raumfahrtsysteme (2)
- Division of Medical Technology and Science, Department of Medical Physics and Engineering, Course of Health Science, Osaka University Graduate School of Medicine, Suita Japan (2)
- EMBL Heidelberg (2)
- Institut for Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Leopold-Franzens-University Innsbruck, Innsbruck, Austria (2)
- Institut für Optik und Atomare Physik, Technische Universität Berlin, 10623 Berlin, Germany (2)
- Institut für Tierökologie und Tropenbiologie (2)
- Interdisciplinary Center for Clinical Research (2)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) (2)
- International Max Planck Research School Molecular Biology, University of Göttingen, Germany (2)
- Johns Hopkins School of Medicine, The Russell H Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA (2)
- Klinische Studienzentrale (Universitätsklinikum) (2)
- Krankenhaushygiene und Antimicrobial Stewardship (2)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (2)
- Krankenhaushygiene und Antimicrobial Stewardship, Universitätsklinikum Würzburg (2)
- Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan (2)
- Lehrkrankenhaus II. Medizinische Klinik Klinikum Coburg (2)
- Lehrstuhl für Regeneration Muskuloskelettaler Gewebe (2)
- Mildred Scheel Early Career Center (2)
- Mildred-Scheel-Nachwuchszentrum (2)
- Open University of the Netherlands (2)
- Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg (2)
- Röntgen Center for Complex Material Systems (RCCM), Am Hubland, 97074 W¨urzburg, Germany (2)
- Siemens AG (2)
- Technische Universität Dresden (2)
- Universität Bayreuth (2)
- Universität Belgrad, Serbien (2)
- Universität Leipzig (2)
- Universitätsklinikum Münster (2)
- Universitätsklinikum Würzburg (2)
- Würzburg-Dresden Cluster of Excellence ct.qmat (2)
- Zentrallabor, Universitätsklinikum Würzburg (2)
- Zentrum für Infektionsforschung (ZINF) Würzburg (2)
- Zentrum für Telematik e.V. (2)
- Ökologische Station Fabrikschleichach (2)
- ACC GmbH Analytical Clinical Concepts (1)
- ALPARC - The Alpine Network of Protected Areas (1)
- ATLAS Collaboration (1)
- Adam Opel AG (1)
- Agricultural Center, BASF SE, 67117 Limburgerhof, Germany (1)
- Airbus Defence and Space GmbH (1)
- Albert-Ludwigs-Universität Freiburg (1)
- Anthropology Department University of Tennessee, Knoxville (1)
- Apotheke, Universitätsklinikum Würzburg (1)
- Arizona State University, Tempe, Arizona, USA (1)
- BMBF (1)
- Bavarian Center for Applied Energy Research (ZAE Bayern), 97074 Würzburg, Germany (1)
- Bavarian Center for Applied Energy Research e.V. (ZAE Bayern) (1)
- Bio-Imaging Center Würzburg (1)
- Biomedical Center Munich, Department of Physiological Chemistry, Ludwig-Maximilians-Universität München (1)
- Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut fuer biophysikalische Chemie (1)
- Birmingham City University (1)
- Blindeninstitut, Ohmstr. 7, 97076, Wuerzburg, Germany (1)
- Boehringer Ingelheim Pharma GmbH & Co. KG (1)
- Brown University (1)
- Bundesinstitut für Arzneimittel und Medizinprodukte (1)
- Bundeswehr Institute of Radiobiology affiliated to the University of Ulm, Munich, Germany (1)
- CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - the development agency of the Brazilian Federal Government (1)
- CERN (1)
- CERN (Geneva, Switzerland) (1)
- CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg (1)
- California Institute of Technology (1)
- Carl-Ludwig-Institut für Physiologie, Universität Leipzig (1)
- Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Göttingen, Germany (1)
- Center for Nanosystems Chemistry (1)
- Center for Nanosystems Chemistry (CNC), University of Würzburg (1)
- Center for Nanosystems Chemistry (CNC), Universität Würzburg (1)
- Center for Nanosystems Chemistry (CNC), Universität Würzburg, Am Hubland, 97074 Würzburg, Germany (1)
- Center of Excellence for Science and Technology - Integration of Mediterranean region (STIM), Faculty of Science, University of Split, Poljička cesta 35, 2100 Split, Croatia (1)
- Centre for Political Studies, Jawaharlal Nehru University, New Delhi (1)
- Chair of Experimental Biomedicine I (1)
- Charles University, Faculty of Mathematics and Physics, Ke Karlovu 5, 121 16 Prague, Czech Republic (1)
- Cheng Lab, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA (1)
- Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells, Göttingen (1)
- Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany (1)
- Comprehensive Hearing Center, Department of ORL, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Würzburg, Germany (1)
- Core Unit Systemmedizin (1)
- DAAD - Deutscher Akademischer Austauschdienst (1)
- DATE Lab, KITE Research Insititute, University Health Network, Toronto, Canada (1)
- DLR (1)
- DNA Analytics Core Facility, Biocenter, University of Wuerzburg, Wuerzburg, Germany (1)
- DNA Analytics Core Facility, Biocenter, University of Würzburg, Würzburg, Germany (1)
- Datenintegrationszentrum Würzburg (DIZ) (1)
- Deakin University, Australia (1)
- Departamento de Química, Facultad de Ciencias, Universidad Autónoma de Madrid, 28049 Madrid, Spain (1)
- Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany (1)
- Department of Biochemistry (1)
- Department of Cellular Biochemistry, University Medical Center Göttingen (1)
- Department of Cellular Biochemistry, University Medical Centre Göttingen (1)
- Department of Cellular Therapies, University of Navarra, Pamplona, Spain (1)
- Department of Chemistry, Humboldt Universität zu Berlin, Brook-Taylor-Strasse 2, 12489 Berlin, Germany (1)
- Department of Chemistry, Sungkyunkwan University, 440-746 Suwon, Republic of Korea (1)
- Department of English, Jamia Millia Islamia (A Central University), New Delhi (1)
- Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany (1)
- Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden (1)
- Department of Mathematical Analysis, Faculty of Mathematics and Physics, Charles University in Prague (1)
- Department of Medicinal Chemistry, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Department of Medicine A, University Hospital of Münster, Münster, Germany (1)
- Department of Molecular Biology, University Medical Center Göttingen, Germany (1)
- Department of Molecular Biology, University Medical Centre Göttingen (1)
- Department of Molecular Biology, University Medical Centre Göttingen, Göttingen 37073, Germany (1)
- Department of Nuclear Medicine, Kanazawa University (1)
- Department of Nuclear Medicine, Philipps University Marburg, Marburg, Germany (1)
- Department of Paediatric Radiology, Institute of Diagnostic and Interventional Radiology, Josef-Schneider-Straße 2, Wuerzburg 97080, Germany (1)
- Department of Pediatrics, Pediatrics I, Innsbruck Medical University, Anichstr. 35, 6020, Innsbruck, Austria (1)
- Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Department of Veterinary Sciences, Experimental Parasitology, Ludwig-Maximilians-Universität München (1)
- Department of X-ray Microscopy, University of Würzburg, Würzburg, Germany (1)
- Deutscher Akademischer Austauschdienst (DAAD) (1)
- Deutsches Archäologisches Institut (1)
- Deutsches Krebsforschungszentrum Heidelberg (1)
- Deutsches Zentrum für Luft & Raumfahrt (DLR) (1)
- Deutsches Zentrum für Luft- und Raumfahrt (1)
- Deutsches Zentrum für Luft- und Raumfahrt (DLR) (1)
- Deutsches Zentrum für Luft- und Raumfahrt e.V. (1)
- Deutsches Zentrum für Präventionsforschung Psychische Gesundheit (DZPP) (1)
- EMBL Mouse Biology Unit, Monterotondo, Italien (1)
- EMBL, Structural and Computational Biology Unit, Heidelberg, Germany (1)
- ESPCI Paris (1)
- Eberhard Karls Universität Tübingen (1)
- English Department, University of Zurich (1)
- Ernst Strüngmann Institute for Neuroscience in Cooperation with Max Planck Society (ESI) (1)
- Eurac research (1)
- European Molecular Biology Laboratory, Heidelberg, Germany (1)
- European Space Agency (1)
- Evangelisches Studienwerk e.V. (1)
- Experimental Physics V, University of Wuerzburg (1)
- Expertenkreis zur Erarbeitung eines Stufenplans zur Diagnose und Therapie von Angsterkrankungen (1)
- Fachbereich Physik, Universität Konstanz, D-78464 Konstanz, Germany (1)
- Fachgebiet für Populationsgenomik bei Nutztieren, Universität Hohenheim (1)
- Fakultät für Physik, Universität Bielefeld (1)
- Forschungsstation Fabrikschleichach (1)
- Forschungsverbund ForChange des Bayrischen Kultusministeriums (1)
- Fraunhofer ISC (1)
- Fraunhofer Insitut für Silicatforschung ISC (1)
- Fraunhofer Institute Interfacial Engineering and Biotechnology (IGB) (1)
- Fraunhofer Institute for Silicate Research ISC in Würzburg (1)
- Fraunhofer-Institut für Chemische Technologie (ICT) (1)
- Fraunhofer-Institute for Applied Optics and Precision Engineering IOF Jena, Germany (1)
- Fraunhofer-Institute for Silicate Research ISC (1)
- Friedrich Schiller University Jena, Germany (1)
- Friedrich-Schiller-Universität Jena (1)
- GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel (1)
- Genelux Corporation, San Diego Science Center, 3030 Bunker Hill Street, Suite 310, San Diego, California 92109, USA (1)
- Georg August University School of Science (1)
- Goethe-Universität Frankfurt (1)
- Göttingen Center for Molecular Biosciences, Georg- August University Göttingen, Göttingen 37077, Germany (1)
- Göttingen Center for Molecular Biosciences, University of Göttingen (1)
- Harvard Medical School, Boston, USA (1)
- Helmholtz Center for RNA-based Infection Research (1)
- Helmholtz Institut für RNA-basierte Infektionsforschung (1)
- Helmholtz Institute for RNA-based Infection Biology (HIRI), Josef-Schneider-Straße 2/D15, DE-9708 Wuerzburg, Germany (1)
- Helmholtz Institute for RNA-based Infection Biology (HIRI), Josef-Schneider-Straße 2/D15, DE-97080 Wuerzburg, Germany (1)
- Helmholtz Institute for RNA-based Infection Research (1)
- Helmholtz-Institut für RNA-basierte Infektionsforschung (1)
- Hospital Augsburg, Augsburg, Germany (1)
- IBMP - Institut für Biomedizinische und Pharmazeutische Forschung in Nürnberg-Heroldsberg (1)
- INAF Padova, Italy (1)
- IZKF (Interdisziplinäres Zentrum für Klinische Forschung), Universität Würzburg (1)
- IZKF Laboratory for Microarray Applications, University Hospital of Wuerzburg, Wuerzburg, Germany (1)
- Institut Ruđer Bošković, Zagreb, Croatia (1)
- Institut für Evangelische Theologie und Religionspädagogik (1)
- Institut für Hygiene und Mikrobiologie (1)
- Institut für Medizinische Mikrobiologie und Hygiene der Eberhard-Karls-Universität Tübingen (1)
- Institut für Molekulare Infektionsbiologie (MIB) der Universität Würzburg (1)
- Institut für Organische Chemie, RWTH Aachen (1)
- Institut für klinische Neurobiologie (1)
- Institute for Biochemistry I, University of Cologne (1)
- Institute for Sustainable Chemistry & Catalysis with Boron (1)
- Institute of Cancer Research (ICR) London (1)
- Institute of Organic Chemistry and Center for Molecular Biosciences Innsbruck, CMBI, Leopold-Franzens University Innsbruck, Austria (1)
- Institute of Physics and Center for Nanotechnology, University of Münster (1)
- Institute of Transformative Bio-Molecules, Nagoya University, Nagoya, Japan (1)
- Instituto de Higiene, Universidad de la República, Montevideo, Uruguay (1)
- Instituto de Hygiene Montevideo, Uruguay (1)
- Integriertes Forschungs und Behandlungszentrum Adipositaserkrankungen (1)
- Interdisciplinary Bank of Biological Material and Data Würzburg (IBDW) (1)
- Interdisciplinary Center for Clinical Research (IZKF), Würzburg, Germany (1)
- Interdisziplinäre Biomaterial- und Datenbank Würzburg (ibdw) (1)
- Interdisziplinäre Zentrum für Klinische Forschung (IZKF) (1)
- Interdisziplinäres Amyloidosezentrum Nordbayern (1)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) Würzburg (1)
- Interdisziplinäres Zentrum für Klinische Forschung (ZIKF), Würzburg (1)
- International Society for Nutritional Psychiatric Research (1)
- Istituto di Chimica dei Composti Organometallici (ICCOM–CNR), Area della Ricerca del CNR, Via Moruzzi 1, I-56124 Pisa, Italy. (1)
- Jacobs University Bremen, Germany (1)
- Johns Hopkins Medicine (1)
- Johns Hopkins School of Medicine, Baltimore, MD, USA (1)
- Johns Hopkins University School of Medicine, Baltimore, MD, U.S. (1)
- Johns Hopkins University, Baltimore, MD, U.S. (1)
- Johns Hopkis School of Medicine (1)
- Joslin Diabetes Center, Harvard Medical School (1)
- Julius-Maximilians-Universität Würzburg (JMU), Department of English and American Studies (1)
- Julius-von-Sachs-Institut für Biowissenschaften Lehrstuhl für Botanik II - Ökophysiologie und Vegetationsökologie (1)
- Julius-von-Sachs-Institut für Biowissenschaften mit Botanischem Garten. Lehrstuhl für Pharmazeutische Biologie (1)
- Klinik für Psychiatrie und Psychotherapie, Universität Würzburg (1)
- Klinik und Poliklinik für Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie des Universitätsklinikums Würzburg (1)
- Klinische Mikrobiologie am Universitätsklinikum Erlangen (1)
- König-Ludwig-Haus, Orthopedic Clinic, Würzburg (1)
- LIDYL, CEA, CNRS, Université Paris-Saclay, CEA Saclay 91191 Gif-sur-Yvette France (1)
- LMU München (1)
- Landesbetrieb Landwirtschaft Hessen, Bieneninstitut Kirchhain (1)
- Lehrstuhl für BioMolekulare Optik, Ludwig-Maximilians-Universität München (1)
- Lehrstuhl für Bioinformatik (1)
- Lehrstuhl für Fernerkundung der Uni Würzburg, in Kooperation mit dem Deutschen Fernerkundungsdatenzentrum (DFD) des Deutschen Zentrums für Luft- und Raumfahrt (DLR) (1)
- Lehrstuhl für Röntgenmikroskopie (1)
- Lehrstuhl für Tierökologie und Tropenbiologie, Universität Würzburg (1)
- Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V. (1)
- Leuphana Universität Lüneburg (1)
- MRB Forschungszentrum für Magnet-Resonanz-Bayern e.V., Am Hubland, D-97074 Würzburg (1)
- MRB Research Center for Magnetic-Resonance-Bavaria (1)
- Maastricht University, Department of Psychiatry and Neuropsychology (1)
- Maastricht University, Maastricht, the Netherlands (1)
- Mathematical Institute, Czech Academy of Sciences (1)
- Max Delbrück Center for Molecular Medicine (1)
- Max Planck Institute for Biophysical Chemistry (1)
- Max Planck Institute for Biophysical Chemistry, Am Faßberg 11, DE-37077 Goetingen, Germany (1)
- Max Planck Institute for Biophysical Chemistry, Department of Molecular Biology, Göttingen (1)
- Max Planck Institute for Biophysical Chemistry, Research Group Structure and Function of Molecular Machines, Göttingen (1)
- Max Planck School of Photonics Jena, Germany (1)
- Max-Delbrück-Center für molekulare Medizin, Berlin (1)
- Max-Planck Institute for Biophysical Chemistry, Department of Molecular Biology, Göttingen (1)
- Max-Planck-Institut für Kognitions- und Neurowissenschaften (1)
- Medizinische Klinik und Poliklinik 1, Abteilung Kardiologie (1)
- Medizinische Klinik und Poliklinik 1, Abteilung Nephrologie (1)
- Medizinische Universität Innsbruck (1)
- Michigan State University (1)
- Microarray Core Unit, Interdisciplinary Center for Clinical Science, University of Würzburg, Versbacher Straße, Würzburg 97080, Germany (1)
- Molecular Nutrition Research, Interdisciplinary Research Center, Justus-Liebig-University of Giessen (1)
- Muskuloskelettales Centrum Würzburg (MCW) (1)
- NASA Jet Propulsion Laboratory (1)
- NanoOptics & Biophotonics Group, Experimental Physics 5, Universität Würzburg (1)
- National Cardiovascular and Cerebral Center, Suita, Japan (1)
- National Institute for Materials Science, Tsukuba, Japan (1)
- National Park "Bavarian Forest" (1)
- New York Blood Center (1)
- Novartis AG (1)
- Novartis Pharma AG, Lichtstrasse 35, CH-4056 Basel, Switzerland (1)
- Novartis Pharma AG, Switzerland (1)
- OTH Regensburg (1)
- Opel Automobile GmbH (1)
- Ostbayerische Technische Hochschule Regensburg (1)
- Paul Scherrer Institut (1)
- Paul-Scherrer-Institut, Villigen, CH (1)
- Pharmakologie, Universität Bonn (1)
- Pharmazie, Universität Mailand (1)
- Politecnico di Milano (1)
- Professional School of Education (1)
- Queensland University of Technology (1)
- Research Center for Infectious Diseases (ZINF), University of Wuerzburg, Wuerzburg, Germany, (1)
- Research Center for Infectious Diseases (ZINF), University of Würzburg, Würzburg, Germany (1)
- Research Center for Infectious Diseases, University of Wuerzburg, Wuerzburg 97080, Germany (1)
- Research Center for Infectious Diseases, University of Würzburg (1)
- Research Center for Magnetic-Resonance-Bavaria (MRB), Wuerzburg, Germany (1)
- Research Center of Animal Cognition, Universite Paul Sabatier Toulouse III (1)
- Research Center of Infectious Diseases (ZINF) of the University of Wurzburg, Germany (1)
- Roche Diagnostics GmbH Penzberg (1)
- Rudolf-Virchow-Zentrum für Experimentelle Biomedizin der Universität Würzburg (1)
- Röntgen Research Center for Complex Material Systems, Hubland Campus Nord, Emil-Fischer-Straße 42, D-97074 Würzburg, Germany (1)
- Sahin Lab, F.M. Kirby Neurobiology Center Boston Children’s Hospital, Department of Neurology, Harvard Medical School (1)
- Salzburg Institute for Regional Planning and Housing (1)
- Service Centre InterNational Transfer (Universität Würzburg) (1)
- Servicezentrum Medizin-Informatik (1)
- Servicezentrum Medizin-Informatik (Universitätsklinikum) (1)
- Siemens Corporate Technology Munich (1)
- Social and Technological Systems (SaTS) lab, School of Art, Media, Performance and Design, York University, Toronto, Canada (1)
- South African National Biodiversity Institute (SANBI) (1)
- Spanish National Center for Biotechnology (CNB-CSIC) (1)
- Spectral Service AG (1)
- Synchrotron SOLEIL, Gif-sur-Yvette (1)
- TH Köln (1)
- Tanzania Food and Drugs Authority (1)
- Technische Universität Darmstadt (1)
- Technische Universität Dortmund, Fakultät für Informatik, Computer Graphics Group (1)
- Technische Universität München (1)
- The Chinese University of Hong Kong (1)
- The Italian Federation of Parks and Nature Reserves (1)
- The University of Sussex (1)
- The project was founded by IZKF (1)
- Tropenmedizin, Klinikum Würzburg Mitte gGmbH, Missioklinik (1)
- Universidade de São Paulo, Programa de Pós-Graduação em Letras Clássicas, São Paulo, Brasil (1)
- University Medical Center Göttingen, Department of Cellular Biochemistry, Göttingen (1)
- University of Applied Sciences Aschaffenburg (1)
- University of Applied Sciences Potsdam (1)
- University of Applied Sciences and Arts Western Switzerland, Fribourg (1)
- University of Bari Medical School, Bari, Italy (1)
- University of Birmingham, Medical School, Institute of Biomedical Research (1)
- University of Cologne (1)
- University of Duisburg-Essen (1)
- University of Iceland (Human Behaviour Laboratory) (1)
- University of Leipzig, Faculty of Life Sciences, Institute for Biology (1)
- University of Oldenburg, Germany (1)
- University of Padova, Italy (1)
- University of Santa Cruz do Sul, Brazil (1)
- University of Science and Technology of China, Hefei, China (1)
- University of Stellenbosch, Division of Medical Virology (1)
- University of Twente (The Netherlands) (1)
- Universität Bielefeld (1)
- Universität Duisburg-Essen, Institut für Molekularbiologie, AG Becker-Flegler (1)
- Universität Göttingen (1)
- Universität Hamburg (1)
- Universität Würzburg GmbH für Bildungs- und Campusdienstleistungen (1)
- Universitätsklinikum Würzburg (UKW) (1)
- Université Paris I Panthéon-Sorbonne (1)
- Université d'Abomey-Calavi, Benin (1)
- Université de Bordeaux, Bordeaux, France (1)
- Université de Montréal (1)
- Université de Paris-Saclay (1)
- Urban Planning Institute of the Republic of Slovenia (1)
- VIGEA, Italy (1)
- Wilhelm Conrad Röntgen-Center for Complex Material Systems, Würzburg (1)
- Women Writers Project (1)
- Wurzburg Fabry Center for Interdisciplinary Therapy (FAZIT), Wurzburg, Germany (1)
- Würzburg Fabry Center for Interdisciplinary Therapy (FAZIT), University of Würzburg, Würzburg, Germany (1)
- ZINF Research Center for Infectious Diseases (1)
- Zentrum für Infektionsforschung (ZINF): Nachwuchsgruppe 2 (1)
- Zentrum für Infektionsforschung ZINF Würzburg (1)
- Zentrum für Infektionsforschung, Universität Würzburg (1)
- Zentrum für soziale Implikationen künstlicher Intelligenz (SOCAI) (1)
- iDiv (1)
- Ökologische Station, Fabrikschleichach (1)
ResearcherID
- B-1911-2015 (1)
- B-4606-2017 (1)
- C-2593-2016 (1)
- D-1221-2009 (1)
- D-1250-2010 (1)
- I-5818-2014 (1)
- J-8841-2015 (1)
- M-1240-2017 (1)
- N-2030-2015 (1)
- N-3741-2015 (1)
This paper presents measurements of the W+->mu+nu and W-->mu-nu cross-sections and the associated charge asymmetry as a function of the absolute pseudorapidity of the decay muon. The data were collected in proton-proton collisions at a centre-of-mass energy of 8 TeV with the ATLAS experiment at the LHC and correspond to a total integrated luminosity of 20.2fb(-1). The precision of the cross-section measurements varies between 0.8 and 1.5% as a function of the pseudorapidity, excluding the 1.9% uncertainty on the integrated luminosity. The charge asymmetry is measured with an uncertainty between 0.002 and 0.003. The results are compared with predictions based on next-to-next-to-leading-order calculations with various parton distribution functions and have the sensitivity to discriminate between them.
This Letter describes the observation of the light-by-light scattering process, gamma gamma -> gamma gamma, in Pb + Pb collisions at root S-NN = 5.02 TeV. The analysis is conducted using a data sample corresponding to an integrated luminosity of 1.73 nb(-1), collected in November 2018 by the ATLAS experiment at the LHC. Light-by-light scattering candidates are selected in events with two photons produced exclusively, each with transverse energy E-T(gamma) > 3 GeV and pseudorapidity vertical bar eta(gamma)vertical bar < 2.4, diphoton invariant mass above 6 GeV, and small diphoton transverse momentum and acoplanarity. After applying all selection criteria, 59 candidate events are observed for a background expectation of 12 +/- 3 events. The observed excess of events over the expected background has a significance of 8.2 standard deviations. The measured fiducial cross section is 78 +/- 13(stat) +/- 7(syst) +/- 3(lumi) nb.
This paper describes a study of techniques for identifying Higgs bosons at high transverse momenta decaying into bottom-quark pairs, H -> b (b) over bar, for proton-proton collision data collected by the ATLAS detector at the Large Hadron Collider at a centre-of-mass energy root s = 13 TeV. These decays are reconstructed from calorimeter jets found with the anti-k(t) R = 1.0 jet algorithm. To tag Higgs bosons, a combination of requirements is used: b-tagging of R = 0.2 track-jets matched to the large-R calorimeter jet, and requirements on the jet mass and other jet substructure variables. The Higgs boson tagging efficiency and corresponding multijet and hadronic top-quark background rejections are evaluated using Monte Carlo simulation. Several benchmark tagging selections are defined for different signal efficiency targets. The modelling of the relevant input distributions used to tag Higgs bosons is studied in 36 fb(-1) of data collected in 2015 and 2016 using g -> b (b) over bar and Z(-> b (b) over bar)gamma event selections in data. Both processes are found to be well modelled within the statistical and systematic uncertainties.
The inclusive cross-section for jet production in association with a Z boson decaying into an electronpositron pair is measured as a function of the transverse momentum and the absolute rapidity of jets using 19.9 fb(-1) of root s = 8 TeV proton-proton collision data collected with the ATLAS detector at the Large Hadron Collider. The measured Z + jets cross-section is unfolded to the particle level. The cross-section is compared with state-of-the-art Standard Model calculations, including the next-to-leading-order and next-to-next-to-leading-order perturbative QCD calculations, corrected for non-perturbative and QED radiation effects. The results of the measurements cover final-state jets with transverse momenta up to 1 TeV, and show good agreement with fixed-order calculations.
Narrow resonances decaying into WW, WZ or ZZ boson pairs are searched for in 139 fb(-1) of proton-proton collision data at a centre-of-mass energy of root s = 13TeV recorded with the ATLAS detector at the Large Hadron Collider from 2015 to 2018. The diboson system is reconstructed using pairs of high transverse momentum, large-radius jets. These jets are built from a combination of calorimeter- and tracker-inputs compatible with the hadronic decay of a boosted W or Z boson, using jet mass and substructure properties. The search is performed for diboson resonances with masses greater than 1.3TeV. No significant deviations from the background expectations are observed. Exclusion limits at the 95% confidence level are set on the production cross-section times branching ratio into dibosons for resonances in a range of theories beyond the Standard Model, with the highest excluded mass of a new gauge boson at 3.8TeV in the context of mass-degenerate resonances that couple predominantly to gauge bosons.
In response to the 2013 Update of the European Strategy for Particle Physics (EPPSU), the Future Circular Collider (FCC) study was launched as a world-wide international collaboration hosted by CERN. The FCC study covered an energy-frontier hadron collider (FCC-hh), a highest-luminosity high-energy lepton collider (FCC-ee), the corresponding 100km tunnel infrastructure, as well as the physics opportunities of these two colliders, and a high-energy LHC, based on FCC-hh technology. This document constitutes the third volume of the FCC Conceptual Design Report, devoted to the hadron collider FCC-hh. It summarizes the FCC-hh physics discovery opportunities, presents the FCC-hh accelerator design, performance reach, and staged operation plan, discusses the underlying technologies, the civil engineering and technical infrastructure, and also sketches a possible implementation. Combining ingredients from the Large Hadron Collider (LHC), the high-luminosity LHC upgrade and adding novel technologies and approaches, the FCC-hh design aims at significantly extending the energy frontier to 100TeV. Its unprecedented centre of-mass collision energy will make the FCC-hh a unique instrument to explore physics beyond the Standard Model, offering great direct sensitivity to new physics and discoveries.
In response to the 2013 Update of the European Strategy for Particle Physics (EPPSU), the Future Circular Collider (FCC) study was launched as a world-wide international collaboration hosted by CERN. The FCC study covered an energy-frontier hadron collider (FCC-hh), a highest-luminosity high-energy lepton collider (FCC-ee), the corresponding 100 km tunnel infrastructure, as well as the physics opportunities of these two colliders, and a high-energy LHC, based on FCC-hh technology. This document constitutes the third volume of the FCC Conceptual Design Report, devoted to the hadron collider FCC-hh. It summarizes the FCC-hh physics discovery opportunities, presents the FCC-hh accelerator design, performance reach, and staged operation plan, discusses the underlying technologies, the civil engineering and technical infrastructure, and also sketches a possible implementation. Combining ingredients from the Large Hadron Collider (LHC), the high-luminosity LHC upgrade and adding novel technologies and approaches, the FCC-hh design aims at significantly extending the energy frontier to 100 TeV. Its unprecedented centre-of-mass collision energy will make the FCC-hh a unique instrument to explore physics beyond the Standard Model, offering great direct sensitivity to new physics and discoveries.
We review the physics opportunities of the Future Circular Collider, covering its e(+)e(-), pp, ep and heavy ion programmes. We describe the measurement capabilities of each FCC component, addressing the study of electroweak, Higgs and strong interactions, the top quark and flavour, as well as phenomena beyond the Standard Model. We highlight the synergy and complementarity of the different colliders, which will contribute to a uniquely coherent and ambitious research programme, providing an unmatchable combination of precision and sensitivity to new physics.
In response to the 2013 Update of the European Strategy for Particle Physics, the Future Circular Collider (FCC) study was launched, as an international collaboration hosted by CERN. This study covers a highest-luminosity high-energy lepton collider (FCC-ee) and an energy-frontier hadron collider (FCC-hh), which could, successively, be installed in the same 100 km tunnel. The scientific capabilities of the integrated FCC programme would serve the worldwide community throughout the 21st century. The FCC study also investigates an LHC energy upgrade, using FCC-hh technology. This document constitutes the second volume of the FCC Conceptual Design Report, devoted to the electron-positron collider FCC-ee. After summarizing the physics discovery opportunities, it presents the accelerator design, performance reach, a staged operation scenario, the underlying technologies, civil engineering, technical infrastructure, and an implementation plan. FCC-ee can be built with today's technology. Most of the FCC-ee infrastructure could be reused for FCC-hh. Combining concepts from past and present lepton colliders and adding a few novel elements, the FCC-ee design promises outstandingly high luminosity. This will make the FCC-ee a unique precision instrument to study the heaviest known particles (Z, W and H bosons and the top quark), offering great direct and indirect sensitivity to new physics.
A search for a heavy neutral Higgs boson, A, decaying into a Z boson and another heavy Higgs boson, H, is performed using a data sample corresponding to an integrated luminosity of 36.1 fb(-1) from proton-proton collisions at root s = 13 TeV recorded in 2015 and 2016 by the ATLAS detector at the Large Hadron Collider. The search considers the Z boson decaying to electrons or muons and the H boson into a pair of b-quarks. No evidence for the production of an A boson is found. Considering each production process separately, the 95% confidence-level upper limits on the pp -> A -> ZH production cross-section times the branching ratio H -> bb are in the range of 14-830 fb for the gluon-gluon fusion process and 26-570 fb for the b-associated process for the mass ranges 130-700 GeV of the H boson and 230-800 GeV of the A boson. The results are interpreted in the context of two-Higgs-doublet models. (C) 2018 Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). Funded by SCOAP(3).
The mass of the Higgs boson is measured in the H -> ZZ* -> 4l and in the H -> gamma gamma decay channels with 36.1 fb(-1) of proton-proton collision data from the Large Hadron Collider at a centre-of-mass energy of 13 TeV recorded by the ATLAS detector in 2015 and 2016. The measured value in the H -> ZZ* -> 4l channel is m(H)(ZZ*) = 124.79 +/- 0.37 GeV, while the measured value in the H -> gamma gamma channel is m(H)(gamma gamma) = 124.93 +/- 0.40 GeV. Combining these results with the ATLAS measurement based on 7 and 8 TeV proton-proton collision data yields a Higgs boson mass of m(H) = 124.97 +/- 0.24 GeV. (c) 2018 The Author. Published by Elsevier B.V.
This Letter presents a search for exotic decays of the Higgs boson to a pair of new (pseudo) scalar particles, H -> aa, where the a particle has a mass in the range 20-60 GeV, and where one of the a bosons decays into a pair of photons and the other to a pair of gluons. The search is performed in event samples enhanced in vector-boson fusion Higgs boson production by requiring two jets with large invariant mass in addition to the Higgs boson candidate decay products. The analysis is based on the full dataset of pp collisions at root s = 13 TeV recorded in 2015 and 2016 with the ATLAS detector at the CERN Large Hadron Collider, corresponding to an integrated luminosity of 36.7 fb(-1). The data are in agreement with the Standard Model predictions and an upper limit at the 95% confidence level is placed on the production cross section times the branching ratio for the decay H -> aa -> gamma gamma gg. This limit ranges from 3.1 pb to 9.0 pb depending on the mass of the a boson. (C) 2018 The Author. Published by Elsevier B.V.
A search for the standard model Higgs boson produced in association with a top-quark pair, t(t)overbarH, is presented. The analysis uses 36.1 fb(-1) of pp collision data at root s = 13 TeV collected with the ATLAS detector at the Large Hadron Collider in 2015 and 2016. The search targets the H -> b(b)overbar decay mode. The selected events contain either one or two electrons or muons from the top-quark decays, and are then categorized according to the number of jets and how likely these are to contain b-hadrons. Multivariate techniques are used to discriminate between signal and background events, the latter being dominated by ft + jets production. For a Higgs boson mass of 125 GeV, the ratio of the measured t(t)overbarH signal cross-section to the standard model expectation is found to be mu = 0.84(-0.61)(+0.64). A value of mu greater than 2.0 is excluded at 95% confidence level (C.L.) while the expected upper limit is mu < 1.2 in the absence of a t(t)overbarH signal.
A search for the associated production of the Higgs boson with a top quark pair (tt (b) over barH) is reported. The search is performed in multilepton final states using a data set corresponding to an integrated luminosity of 36.1 fb(-1) of proton-proton collision data recorded by the ATLAS experiment at a center-of-mass energy root s = 13 TeV at the Large Hadron Collider. Higgs boson decays to WW*, tau tau, and ZZ* are targeted. Seven final states, categorized by the number and flavor of charged-lepton candidates, are examined for the presence of the Standard Model Higgs boson with a mass of 125 GeVand a pair of top quarks. An excess of events over the expected background from Standard Model processes is found with an observed significance of 4.1 standard deviations, compared to an expectation of 2.8 standard deviations. The best fit for the (tt (b) over barH) production cross section is sot (tt (b) over barH) = 790(-210)(+230) fb, in agreement with the Standard Model prediction of 507(-50)(+35) fb. The combination of this result with other tt (b) over barH searches from the ATLAS experiment using the Higgs boson decay modes to b (b) over bar, gamma gamma and ZZ* -> 4l, has an observed significance of 4.2 standard deviations, compared to an expectation of 3.8 standard deviations. This provides evidence for the tt (b) over barH production mode.
A search is presented for photonic signatures, motivated by generalized models of gauge-mediated supersymmetry breaking. This search makes use of proton-proton collision data at root s = 13 TeV corresponding to an integrated luminosity of 36.1 fb(-1) recorded by the ATLAS detector at the LHC, and it explores models dominated by both strong and electroweak production of supersymmetric partner states. Experimental signatures incorporating an isolated photon and significant missing transverse momentum are explored. These signatures include events with an additional photon or additional jet activity not associated with any specific underlying quark flavor. No significant excess of events is observed above the Standard Model prediction, and 95% confidence-level upper limits of between 0.083 and 0.32 fb are set on the visible cross section of contributions from physics beyond the Standard Model. These results are interpreted in terms of lower limits on the masses of gluinos, squarks, and gauginos in the context of generalized models of gauge-mediated supersymmetry, which reach as high as 2.3 TeV for strongly produced and 1.3 TeV for weakly produced supersymmetric partner pairs.
Results of dedicated Monte Carlo simulations of beam-induced background (BIB) in the ATLAS experiment at the Large Hadron Collider (LHC) are presented and compared with data recorded in 2012. During normal physics operation this background arises mainly from scattering of the 4 TeV protons on residual gas in the beam pipe. Methods of reconstructing the BIB signals in the ATLAS detector, developed and implemented in the simulation chain based on the FLUKA Monte Carlo simulation package, are described. The interaction rates are determined from the residual gas pressure distribution in the LHC ring in order to set an absolute scale on the predicted rates of BIB so that they can be compared quantitatively with data. Through these comparisons the origins of the BIB leading to different observables in the ATLAS detectors are analysed. The level of agreement between simulation results and BIB measurements by ATLAS in 2012 demonstrates that a good understanding of the origin of BIB has been reached.
This paper reports searches for heavy resonances decaying into ZZ or ZW using data from proton-proton collisions at a centre-of-mass energy of root s - 13 TeV. The data, corresponding to an integrated luminosity of 36.1 fb(-1), were recorded with the ATLAS detector in 2015 and 2016 at the Large Hadron Collider. The searches are performed in final states in which one Z boson decays into either a pair of light charged leptons (electrons and muons) or a pair of neutrinos, and the associated W boson or the other Z boson decays hadronically. No evidence of the production of heavy resonances is observed. Upper bounds on the production cross sections of heavy resonances times their decay branching ratios to ZZ or ZW are derived in the mass range 300-5000 GeV within the context of Standard Model extensions with additional Higgs bosons, a heavy vector triplet or warped extra dimensions. Production through gluon-gluon fusion, Drell-Yan or vector-boson fusion are considered, depending on the assumed model.
A search for W'-boson production in the W' -> t (b) over bar -> q (q) over bar 'b (b) over bar decay channel is presented using 36.1 fb(-1) of 13 TeV proton-proton collision data collected by the ATLAS detector at the Large Hadron Collider in 2015 and 2016. The search is interpreted in terms of both a left-handed and a right-handed chiral W' boson within the mass range 1-5 TeV. Identification of the hadronically decaying top quark is performed using jet substructure tagging techniques based on a shower deconstruction algorithm. No significant deviation from the Standard Model prediction is observed and the results are expressed as upper limits on the W' -> t (b) over bar production cross-section times branching ratio as a function of the W'-boson mass. These limits exclude W' bosons with right-handed couplings with masses below 3.0 TeV and W' bosons with left-handed couplings with masses below 2.9 TeV, at the 95% confidence level. (C) 2018 The Author. Published by Elsevier B.V.
Results of a search for gluino pair production with subsequent R-parity-violating decays to quarks are presented. This search uses 36.1 fb(-1) of data collected by the ATLAS detector in proton-proton collisions with a centre-of-mass energy of root s = 13 TeV at the LHC. The analysis is performed using requirements on the number of jets and the number of jets tagged as containing a b-hadron as well as a topological observable formed by the scalar sum of masses of large-radius jets in the event. No significant excess above the expected Standard Model background is observed. Limits are set on the production of gluinos in models with the R-parity-violating decays of either the gluino itself (direct decay) or the neutralino produced in the R-parity-conserving gluino decay (cascade decay). In the gluino cascade decay model, gluino masses below 1850 GeV are excluded for 1000 GeV neutralino mass. For the gluino direct decay model, the 95% confidence level upper limit on the cross section times branching ratio varies between 0.80 fb at m((g) over tilde) = 900 GeV and 0.011 fb at m((g) over tilde) = 1800 GeV. (c) 2018 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license.
Background
Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surgery more feasible and might be more likely to eradicate micrometastatic disease than might the same chemotherapy given after surgery. We investigated the long-term benefits and risks of NACT and the influence of tumour characteristics on outcome with a collaborative meta-analysis of individual patient data from relevant randomised trials.
Methods
We obtained information about prerandomisation tumour characteristics, clinical tumour response, surgery, recurrence, and mortality for 4756 women in ten randomised trials in early breast cancer that began before 2005 and compared NACT with the same chemotherapy given postoperatively. Primary outcomes were tumour response, extent of local therapy, local and distant recurrence, breast cancer death, and overall mortality. Analyses by intention-to-treat used standard regression (for response and frequency of breast-conserving therapy) and log-rank methods (for recurrence and mortality).
Findings
Patients entered the trials from 1983 to 2002 and median follow-up was 9 years (IQR 5-14), with the last follow-up in 2013. Most chemotherapy was anthracycline based (3838 [81%] of 4756 women). More than two thirds (1349 [69%] of 1947) of women allocated NACT had a complete or partial clinical response. Patients allocated NACT had an increased frequency of breast-conserving therapy (1504 [65%] of 2320 treated with NACT vs 1135 [49%] of 2318 treated with adjuvant chemotherapy). NACT was associated with more frequent local recurrence than was adjuvant chemotherapy: the 15 year local recurrence was 21.4% for NACT versus 15.9% for adjuvant chemotherapy (5.5% increase [95% CI 2.4-8.6]; rate ratio 1.37 [95% CI 1.17-1.61]; p = 0.0001). No significant difference between NACT and adjuvant chemotherapy was noted for distant recurrence (15 year risk 38.2% for NACT vs 38.0% for adjuvant chemotherapy; rate ratio 1.02 [95% CI 0.92-1.14]; p = 0.66), breast cancer mortality (34.4% vs 33.7%; 1.06 [0.95-1.18]; p = 0.31), or death from any cause (40.9% vs 41.2%; 1.04 [0.94-1.15]; p = 0.45).
Interpretation
Tumours downsized by NACT might have higher local recurrence after breast-conserving therapy than might tumours of the same dimensions in women who have not received NACT. Strategies to mitigate the increased local recurrence after breast-conserving therapy in tumours downsized by NACT should be considered-eg, careful tumour localisation, detailed pathological assessment, and appropriate radiotherapy. Copyright (c) The Author(s). Published by Elsevier Ltd.